Skip to main content

“A Phase 2/3, Multicenter, Randomized, Double-blind, Placebo controlled Trial of the Safety and Efficacy of Flexible Doses of SEP-363856 as Adjunctive Therapy in the Treatment of Adults with Major Depressive Disorder'

  • Protocol code: 382-201-00001
  • EudraCT code: No aplica
  • Research group: Psychiatry, Mental Health and Addictions
  • Service: Psychiatry
  • Principal investigator:  Ramos Quiroga, José Antonio
  • Pathology: Trastorns mentals i del comportament
  • Phase: Fase III